Table of Contents Author Guidelines Submit a Manuscript
Obstetrics and Gynecology International
Volume 2013, Article ID 828165, 10 pages
http://dx.doi.org/10.1155/2013/828165
Research Article

Strategies for Molecularly Enhanced Chemotherapy to Achieve Synthetic Lethality in Endometrial Tumors with Mutant p53

1Department of Obstetrics and Gynecology, University of Iowa Hospitals and Clinics, Iowa City, IA 52242, USA
2Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA 52242, USA
3Gillette Center for Gynecological Oncology, Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA

Received 31 May 2013; Accepted 10 October 2013

Academic Editor: Andrew P. Bradford

Copyright © 2013 Xiangbing Meng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [11 citations]

The following is the list of published articles that have cited the current article.

  • Henry D. Reyes, Kristina W. Thiel, Matthew J. Carlson, Xiangbing Meng, Shujie Yang, Jean-Marie Stephan, and Kimberly K. Leslie, “Comprehensive Profiling of EGFR/HER Receptors for Personalized Treatment of Gynecologic Cancers,” Molecular Diagnosis & Therapy, vol. 18, no. 2, pp. 137–151, 2014. View at Publisher · View at Google Scholar
  • Don S. Dizon, Michael W. Sill, Jeanne M. Schilder, Kathryn F. McGonigle, Zia Rahman, David S. Miller, David G. Mutch, and Kimberly K. Leslie, “A phase II evaluation of nintedanib (BIBF-1120) in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology G,” Gynecologic Oncology, vol. 135, no. 3, pp. 441–445, 2014. View at Publisher · View at Google Scholar
  • Pavla Brachova, Samuel R. Mueting, Eric J. Devor, and Kimberly K. Leslie, “Oncomorphic <i>TP</i>53 Mutations in Gynecologic Cancers Lose the Normal Protein:Protein Interactions with the microRNA Microprocessing Complex,” Journal of Cancer Therapy, vol. 05, no. 06, pp. 506–516, 2014. View at Publisher · View at Google Scholar
  • Angiolo Gadducci, Nora Lanfredini, and Claudia Sergiampietri, “Antiangiogenic agents in gynecological cancer: State of art and perspectives of clinical research,” Critical Reviews in Oncology/Hematology, 2015. View at Publisher · View at Google Scholar
  • Pavla Brachova, Samuel R. Mueting, Matthew J. Carlson, Michael J. Goodheart, Anna M. Button, Sarah L. Mott, Donghai Dai, Kristina W. Thiel, Eric J. Devor, and Kimberly K. Leslie, “TP53 oncomorphic mutations predict resistance to platinum- and taxane-based standard chemotherapy in patients diagnosed with advanced serous ovarian c,” International Journal Of Oncology, vol. 46, no. 2, pp. 607–618, 2015. View at Publisher · View at Google Scholar
  • Tatjana Srdic-Rajic, Nevena Tisma-Miletic, Milena Cavic, Ksenija Kanjer, Katarina Savikin, Danijel Galun, Aleksandra Konic-Ristic, and Tamara Zoranovic, “ Sensitization of K562 Leukemia Cells to Doxorubicin by the Viscum album Extract ,” Phytotherapy Research, 2015. View at Publisher · View at Google Scholar
  • Tatiana N. Buhtoiarova, Carol A. Brenner, and Meenakshi Singh, “Endometrial Carcinoma,” American Journal of Clinical Pathology, vol. 145, no. 1, pp. 8–21, 2015. View at Publisher · View at Google Scholar
  • Kareem Ebeid, Xiangbing Meng, Kristina W. Thiel, Anh-Vu Do, Sean M. Geary, Angie S. Morris, Erica L. Pham, Amaraporn Wongrakpanich, Yashpal S. Chhonker, Daryl J. Murry, Kimberly K. Leslie, and Aliasger K. Salem, “Synthetically lethal nanoparticles for treatment of endometrial cancer,” Nature Nanotechnology, 2017. View at Publisher · View at Google Scholar
  • Mary Ellen Urick, Meghan L. Rudd, and Daphne W. Bell, “The Molecular Pathology of Serous Endometrial Cancer,” Precision Molecular Pathology of Uterine Cancer, vol. 11, pp. 87–122, 2017. View at Publisher · View at Google Scholar
  • Takahiro Yaguchi, “The endocrine disruptor bisphenol A promotes nuclear ERRγ translocation, facilitating cell proliferation of Grade I endometrial cancer cells via EGF-dependent and EGF-independent pathways,” Molecular and Cellular Biochemistry, 2018. View at Publisher · View at Google Scholar
  • Katharina Bischof, Stian Knappskog, Ingunn Stefansson, Emmet Martin McCormack, Jone Trovik, Henrica Maria Johanna Werner, Kathrine Woie, Bjorn Tore Gjertsen, and Line Bjorge, “High expression of the p53 isoform γ is associated with reduced progression-free survival in uterine serous carcinoma,” BMC Cancer, vol. 18, no. 1, 2018. View at Publisher · View at Google Scholar